Are sex discordant outcomes in COVID-19 related to sex hormones?

Semin Oncol. 2020 Oct;47(5):335-340. doi: 10.1053/j.seminoncol.2020.06.002. Epub 2020 Jun 17.

Abstract

COVID-19 has a clear sex disparity in clinical outcome. Globally, infection rates between men and women are similar; however, men are more likely to have more severe disease and are more likely to die. The causes for this disparity are currently under investigation and are most likely multifactorial. Sex hormones play an important role in the immune response with estrogen seen as immune boosting and testosterone as immunosuppressing. Additionally, an important protease involved in viral entry, TMPRSS2, is regulated by androgens. Many observational and prospective studies are ongoing or initiating to further examine the role of sex hormones in SARS-CoV-2 infection and if modulation of them is a realistic treatment option.

Keywords: ACE; Androgens; COVID-19; Coronavirus; SARS-CoV-2; TMPRSS2.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Androgen Antagonists / therapeutic use
  • COVID-19 / epidemiology
  • COVID-19 / metabolism
  • COVID-19 Drug Treatment*
  • Female
  • Gonadal Steroid Hormones / metabolism*
  • Humans
  • Male
  • Outcome Assessment, Health Care / methods
  • Outcome Assessment, Health Care / statistics & numerical data*
  • Pandemics
  • Protease Inhibitors / therapeutic use
  • Serine Endopeptidases / metabolism*
  • Sex Factors

Substances

  • Androgen Antagonists
  • Gonadal Steroid Hormones
  • Protease Inhibitors
  • Serine Endopeptidases
  • TMPRSS2 protein, human